15YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| Substance P;RPKPQQFFGLM-NH2 | ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-NH2 | 11035-08-8 |
| Substance P: 1-7 | ARG-PRO-LYS-PRO-GLN-GLN-PHE | 68060-49-1 |
| Rhodamine 110, bis-(CBZ-L-isoleucyl-L-prolyl-L- arginine amide), dihydrochloride (BZiPAR) | (Z-ILE-PRO-ARG)2-R110 | |
| RSV M (187-195)??;NAITNAKII | ASN-ALA-ILE-THR-ASN-ALA-LYS-ILE-ILE | |
| Protein Kinase C? Peptide Substrate | ARG-PHE-ALA-VAL-ARG-ASP-MET-ARG-GLN-THR-VAL-ALA-VAL-GLY-VAL-ILE-LYS-ALA-VAL-ASP-LYS-LYS | |
| Substance P (6-11) | GLN-PHE-PHE-GLY-LEU-MET-NH2 | 51165-07-2 |
| Renin Substrate 1 | ARG-GLU(EDANS)-ILE-HIS-PRO-PHE-HIS-LEU-VAL-ILE-HIS-THR-LYS(DABCYL)-ARG | |
| Selectin | 扑草净 | 7287-19-6 |
| Sarafotoxin S6d | CYS-THR-CYS-LYS-ASP-MET-THR-ASP-LYS-GLU-CYS-LEU-TYR-PHE-CYS-HIS-GLN-ASP-ILE-ILE-TRP | |
| Rac1 inhibitory | ARG-GLN-ILE-LYS-ILE-TRP-PHE-GLN-ASN-ARG-ARG-MET-LYS-TRP-LYS-LYS-THR-CYS-LEU-LEU-ILE-SER-TYR-THR-THR-ASN-ALA-PHE-PRO-GLY-GLU-TYR | |
| SRC Kinase Substrate, amide | ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-PTYR-ALA-ALA-ARG-GLY-NH2 | |
| β-Amyloid (31-35) | ALA-LYS-GLU-ARG-LEU-GLU-ALA-LYS-HIS-ARG-GLU-ARG-MET-SER-GLN-VAL-MET: AKERLEAKHRERMSQVM | |
| Myelin Basic Protein (4-14) | GLN-LYS-ARG-PRO-SER-GLN-ARG-SER-LYS-TYR-LEU | 126768-94-3 |
| Rhodamine 110, bis-(p-tosyl-L-glycyl-L-prolyl-L- arginine amide) | (TOS-GLY-PRO-ARG)2-R110 | |
| SCPA | ALA-ARG-PRO-GLY-TYR-LEU-ALA-PHE-PRO-ARG-MET-NH2 | |
| SAP-I | GLY-PHE-ASP-LEU-ASN-GLY-GLY-GLY-VAL-GLY | |
| Scyliorhinin I, Scy I: Shark Substance P Related Peptide;AKFDKFYGLM | ALA-LYS-PHE-ASP-LYS-PHE-TYR-GLY-LEU-MET-NH2 | 103425-21-4 |
| Protein Kinase G Substrate [QKRPRRKDTP];QKRPRRKDTP | GLN-LYS-ARG-PRO-ARG-ARG-LYS-ASP-THR-PRO | |
| RC-160 [Lys(Boc)] | DPHE-CYS-TYR-DTRP-LYS(BOC)-VAL-CYS-TRP-NH2 | |
| SP1??;GFRLTNFGYFEPG | GLY-PHE-ARG-LEU-THR-ASN-PHE-GLY-TYR-PHE-GLU-PRO-GLY | 26685-57-4 |
| SH2 Domain Ligand (2);EPQ-pY-EEIPIYL* | GLU-PRO-GLN-PTYR-GLU-GLU-ILE-PRO-ILE-TYR-LEU | 147612-86-0 |
| SIVmac239-2;NSVLSGKKADELEKI | ASN-SER-VAL-LEU-SER-GLY-LYS-LYS-ALA-ASP-GLU-LEU-GLU-LYS-ILE | |
| ?-Amyloid (1-40) | Β淀粉样肽(1-40)(抗体) | |
| PRRS-PQGAB-N | GLY-SER-SER-LEU-ASP-ASP-PHE-CYS-TYR-ASP-SER-THR | |
| Sialokinin-2??;DTGDKFYGLM-NH2 | ASP-THR-GLY-ASP-LYS-PHE-TYR-GLY-LEU-MET-NH2 | |
| ?Amyloid BRI Peptide (1-34) | GLP-ALA-SER-ASN-CYS-PHE-ALA-ILE-ARG-HIS-PHE-GLU-ASN-LYS-PHE-ALA-VAL-GLU-THR-LEU-ILE-CYS-SER-ARG-THR-VAL-LYS-LYS-ASN-ILE-ILE-GLU-GLU-ASN | |
| Salusin-α | ALA-ILE-PHE-ILE-PHE-ILE-ARG-TRP-LEU-LEU-LYS-LEU-GLY-HIS-HIS-GLY-ARG-ALA-PRO-PRO | 624735-23-5 |
| Protein Kinase C: 660-673 | ALA-GLY-ASN-LYS-VAL-ILE-SER-PRO-SER-GLU-ASP-ARG-ARG-GLN-CYS: AGNKVISPSEDRRQC | |
| SP2;GFRLTNFGYFEPGK | GLY-PHE-ARG-LEU-THR-ASN-PHE-GLY-TYR-PHE-GLU-PRO-GLY-LYS | |
| Rhodamine 110, bis-(CBZ-L-alanyl-L-arginine amide), dihydrochloride | (Z-ALA-ARG)2-R110 | |
| Substance P (9-11) | GLY-LEU-MET-NH2 | 4652-64-6 |
| R-JAG (188 - 206) R - Jagged - 1(188 - 206), Notch Ligand | CYS-ASP-ASP-TYR-TYR-TYR-GLY-PHE-GLY-CYS-ASN-LYS-PHE-GLY-ARG-PRO-ARG-ASP-ASP | |
| Scospondistatin | GLY-PRO-TRP-GLU-ASP-CYS-SER-VAL-SER-CYS-GLY-GLY-GLY-GLU-GLN-LEU-ARG-SER-ARG | |
| Synaptobrevin-2 (75-78) (human, bovine, mouse, rat) | GLN-PHE-GLU-THR | |
| rec Acetyl-Eglin c | AC-THR-GLU-PHE-GLY-SER-GLU-LEU-LYS-SER-PHE-PRO-GLU-VAL-VAL-GLY-LYS-THR-VAL-ASP-GLN-ALA-ARG-GLU-TYR-PHE-THR-LEU-HIS-TYR-PRO-GLN-TYR-ASP-VAL-TYR-PHE-LEU-PRO-GLU-GLY-SER-PRO-VAL-THR-LEU-ASP-LEU-ARG-TYR-ASN-ARG-VAL-ARG-VAL-PHE-TYR-ASN-PRO-GLY-THR-ASN-VAL-VAL- | 96380-69-7 |
| Somatostatin 14;AGCKNFFWKTFTSC(Disulfidebridge:3-14) | 生长抑素 | 51110-01-1 |
| Beta-Amyloid/A4 Protein Precursor (APP) (96-110);Ac-NWCKRGRKQCKTHPH-NH2(Disulfidebond:3-10) | AC-ASN-TRP-CYS-LYS-ARG-GLY-ARG-LYS-GLN-CYS-LYS-THR-HIS-PRO-HIS-NH2 | |
| Substance P: 1-9 | ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY | 57468-17-4 |
| Ser8-GLP-1: 7-36, amide, human | HIS-SER-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-ARG-NH2: HSEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 | 215777-46-1 |
| Rcramp | GLY-LEU-VAL-ARG-LYS-GLY-GLY-GLU-LYS-PHE-GLY-GLU-LYS-LEU-ARG-LYS-ILE-GLY-GLN-LYS-ILE-LYS-GLU-PHE-PHE-GLN-LYS-LEU-ALA-LEU-GLU-ILE-GLU-GLN | |
| β- Amyloid (1-38) | ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY | |
| Substance P: 3-11/Nona-Substance | GLN-GLN-PHE-PHE-GLY-LEU-MET-NH2: QQFFGLM-NH2 | |
| SH2 Domain Ligand (5);Biotin-LC-pY-EEI | BIOTIN-LC-TYR(PO3H2)-GLU-GLU-ILE | 201422-05-1 |
| Rhodamine 110, bis-(succinoyl-L-alanyl-L-alanyl-L- prolyl-L-phenylalanyl amide) | (SUC-ALA-ALA-PRO-PHE)2-R110 | |
| Beta-Amyloid (1-11);DAEFRHDSGYE | β-淀粉样蛋白（1-11） | 190436-05-6 |
| Leiurotoxin I | ALA-PHE-CYS-ASN-LEU-ARG-MET-CYS-GLN-LEU-SER-CYS-ARG-SER-LEU-GLY-LEU-LEU-GLY-LYS-CYS-ILE-GLY-ASP-LYS-CYS-GLU-CYS-VAL-LYS-HIS-NH2 | 142948-19-4 |
| Systemin | 系统素 | 137181-56-7 |
| Substance P: 9-11 | ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET: RPKPQQFFGLM | 40297-96-9 |
| RGD-4C;ACDCRGDCFCG(Disulfidebridge:2-10and4-8) | ALA-CYS-ASP-CYS-ARG-GLY-ASP-CYS-PHE-CYS-GLY(DISULFIDE BRIDGE:CYS2-CYS10, CYS4-CYS8) | 332179-76-7 |
| Sarafotoxin B | CYS-SER-CYS-LYS-ASP-MET-THR-ASP-LYS-GLU-CYS-LEU-TYR-PHE-CYS-HIS-GLN-ASP-VAL-ILE-TRP (DISULFIDE BRIDGE: CYS1-CYS15, CYS3-CYS11) | 120972-53-4 |
| Substance P-methyl ester | ARG-PRO-LYS-PRO: RPKP | 76260-78-1 |
| PRRS-RSAB-N | ALA-GLY-GLY-SER-SER-SER-THR-TYR-GLN-TYR | |
| SMAP 29, Sheep Myeloid Antimicrobial Peptide 29 | ARG-GLY-LEU-ARG-ARG-LEU-GLY-ARG-LYS-ILE-ALA-HIS-GLY-VAL-LYS-LYS-TYR-GLY-PRO-THR-VAL-LEU-ARG-ILE-ILE-ARG-ILE-ALA-GLY | |
| ?-Amyloid Precursor Protein: 732-751 | ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL: DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV | |
| Substance P-Gly-Lys-Arg | ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-GLY-LYS-ARG | |
| SALMF amide 1 (S1) | GLY-PHE-ASN-SER-ALA-LEU-MET-PHE-NH2 | 866459-07-6 |
| ?-Amyloid Peptide (1-42), rat | ASP-ALA-GLU-PHE-GLY-HIS-ASP-SER-GLY-PHE-GLU-VAL-ARG-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA | |
| Synaptobrevin-2 (73-79) (human, bovine, mouse, rat) | ALA-SER-GLN-PHE-GLU-THR-SER | 401933-00-4 |
| RK9, p17 Gag (20-28)??;RLRPGGKKK | ARG-LEU-ARG-PRO-GLY-GLY-LYS-LYS-LYS | |
| Scyliorhinin I, Scy I: Shark Substance P Related Peptide | ALA-LYS-PHE-ASP-LYS-PHE-TYR-GLY-LEU-MET | |
| S6 Kinase Substrate (232-239);RRLSSLRA | ARG-ARG-LEU-SER-SER-LEU-ARG-ALA | 93674-74-9 |
| Protein Kinase C: alpha Peptide | GLY-PRO-LYS-THR-PRO-GLU-GLU-LYS-THR-ALA-ASN-THR-ILE-SER-LYS-PHE-ASP-CYS: GPKTPEEKTANTISKFDC | |
| R-E-D-V | ARG-GLU-ASP-VAL | |
| Ranamargarin | ASP-ASP-ALA-SER-ASP-ARG-ALA-LYS-LYS-PHE-TYR-GLY-LEU-MET-NH2 | |
| Substance P, free acid;RPKPQQFFGLM | ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET | 71977-09-8 |
| β-Amyloid/A4 Protein Precusor (APP) (319-335) | β-Amyloid/A4 Protein Precusor (319-335) | 148914-01-6 |
| PRRS-PQGAB-C | GLY-THR-ASP-TRP-LEU-ALA-ASN-LYS-PHE-ASP-TRP-ALA | |
| Rhodamine 110, bis-(CBZ-L-arginine amide), dihydrochloride (BZAR) | (Z-ARG)2-R110 | |
| RS domain derived peptide??;GRSRSRSRSR | GLY-ARG-SER-ARG-SER-ARG-SER-ARG-SER-ARG | |
| Substrate for Tyrosine Protein Kinase | ARG-ARG-LEU-ILE-GLU-ASP-ASN-GLU-TYR-THR-ALA-ARG-GLY: RRLIEDNEYTARG | |
| Beta-Amyloid (25-35);GSNKGAIIGLM | BETA-淀粉样蛋白片断25-35 | 131602-53-4 |
| Simian Virus 40 Large Tumor Antigen Amino-Terminal Peptide | AC-MET-ASP-ARG-VAL-LEU-SER-ARG-TYR | 120944-71-0 |
| R15K, HIV-1 Inhibitory Peptide | ARG-ILE-GLN-ARG-GLY-PRO-GLY-ARG-ALA-PHE-VAL-THR-ILE-GLY-LYS: RIQRGPGRAFVTIGK | |
| SRC Kinase Substrate | ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-PTYR-ALA-ALA-ARG-GLY | |
| β-Amyloid (22-35) | ARG-GLU-ARG-MET-SER: RERMS | |
| SH2 Domain Ligand (3);Biotin-LC-EPQ-pY-EEIPIYL | BIOTIN-LC-GLU-PRO-GLN-PTYR-GLU-GLU-ILE-PRO-ILE-TYR-LEU | |
| Somatostatin-14 (3-14) | CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS (DISULFIDE BRIDGE:CYS1-CYS12) | 54518-51-3 |
| Somatostatin-14 (3-10) | CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR | 331627-82-8 |
| Rigin | GLY-GLN-PRO-ARG | |
| Somatostatin Tumor Inhibiting Analog;(D-β-Nal)-CYwKVCT-NH2(Disulfidebridge:2-7) | D-Β-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2 (DISULFIDE BRIDGE:CYS2-CYS7 ) | |
| Substance P (7-11)??;FFGLM-NH2 | ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-GLY-LEU-MET-OME: RPKPQQFFGLM-OME | 51165-05-0 |
| Sarafotoxin A | CYS-SER-CYS-LYS-ASP-MET-THR-ASP-LYS-GLU-CYS-LEU-ASN-PHE-CYS-HIS-GLN-ASP-VAL-ILE-TRP (DISULFIDE BRIDGE: CYS1- CYS15, CYS3-CYS11) | 126738-34-9 |
| Substance P (4-11)/Octa-Substance P | GLN-PHE-PHE-GLY-LEU-MET-NH2: QFFGLM-NH2 | 53749-60-3 |
| RLLFT-NH2 PAR1 Inactive or Negative Control Peptide | ARG-LEU-LEU-PHE-THR-NH2 | |
| Semastatin-5A.1 | GLY-PRO-TRP-GLU-ARG-CYS-THR-ALA-GLN-CYS-GLY-GLY-GLY-ILE-GLN-ALA-ARG-ARG-ARG | |
| Substance P: 1-4 | ARG-PRO-LYS-PRO | 57468-16-3 |
| RC-160(Vapreotide) | DPHE-CYS-TYR-DTRP-LYS-VAL-CYS-TRP-NH2 | |
| Sarafotoxin 6c;CTCNDMTDEECLNFCHQDVIW(Disulfidebridge:1-15and3-11) | CYS-THR-CYS-ASN-ASP-MET-THR-ASP-GLU-GLU-CYS-LEU-ASN-PHE-CYS-HIS-GLN-ASP-VAL-ILE-TRP(DISULFIDE BRIDGE: CYS1-CYS15, CYS3-CYS11) | 121695-87-2 |
| RES-701-3 | GLY-ASN-TRP-HIS-GLY-THR-SER-PRO-ASP-TRP-PHE-PHE-ASN-TYR-TYR-TRP | |
| Spantide II | DLYS: NICOTINOYL-PRO-3-PYRIDYLALA-PRO-3,4-DICHLORODPHE-ASN-DTRP-PHE-DTRP-LEU-NLE-NH2 | |
| Somatostatin-14 (2-9) | GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS | |
| R-G-D-T | ARG-GLY-ASP-THR | |
| β-Amyloid (1-28) | Β淀粉样肽(1-28)(抗体) | |
| RSK Substrate, S6 (231-239) | ARG-ARG-ARG-LEU-SER-SER-LEU-ARG-ALA-NH2 | |
| Rhodamine 110, bis-(CBZ-L-phenylalanyl-L-arginine amide), dihydrochloride | (Z-PHE-ARG)2-R110 | |
| Stick Insect Hypertrehalosaemic Factor II | GLP-LEU-THR-PHE-THR-PRO-ASN-TRP-GLY-THR-NH2: GLP-LTFTPNWGT-NH2 | |
| Saposin C22;CEFLVKEVTKLIDNNKTEKEIL | CYS-GLU-PHE-LEU-VAL-LYS-GLU-VAL-THR-LYS-LEU-ILE-ASP-ASN-ASN-LYS-THR-GLU-LYS-GLU-ILE-LEU | |
| (Z-AA)2Rh110;(Z-AA)2Rh110 | (Z-ALA-ALA)2-R110 | |
| Somatostatin Antagonist | C[AMINOHEPTANOYL-PHE-DTRP-LYS-THR: BZL] | 84211-54-1 |
| Renoguanylin (eel) | ALA-ASP-LEU-CYS-GLU-ILE-CYS-ALA-PHE-ALA-ALA-CYS-THR-GLY-CYS-LEU (DISULFIDE BRIDGE: CYS4- CYS12, CYS7-CYS15 ) |
联系方式
